Saturday 17 October 2026
Export NYXH’s income statement to Excel — free account
Nyxoah SA
NYXH Healthcare Medical Instruments & Supplies
Nyxoah SA’s revenue for fiscal 2025 (year ended December 2025) was $11.3 million, up 131.7% from fiscal 2024. In the quarter to June 2026, revenue grew 486.6%, EPS fell 6.35%, free cash flow grew 4.01% and total debt rose 185.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
1.11
0.08
−6.72%
Follow NYXH
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | 4 | 1 | 2 | 3 |
P/E ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | — | 12.18 | 1.70 | 0.30 | 0.68 | (4.39) |
P/S ratio |
— | — | — | 0.00 | 0.00 | 42.03 | 28.11 | 53.54 | 15.46 |
Altman Z″-Score (non-manufacturers) |
— | — | — | 8.70 | 9.27 | 4.61 | 0.12 | (1.17) | (11.73) |
P/FCF ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | — | 7.30 | (0.87) | (1.57) | (2.98) | (2.78) |
P/Operating CF |
— | — | — | (105.79) | (51.29) | (11.60) | (10.64) | (20.88) | (10.46) |
P/B ratio |
— | — | — | 4.81 | 5.65 | 1.08 | 1.25 | 2.14 | 3.15 |
Price to Tangible BV |
— | — | — | 5.93 | 7.31 | 1.61 | 2.38 | 3.85 | 0.00 |
EV/Sales |
— | — | — | 0.00 | 0.00 | 14.90 | 17.56 | 39.38 | 14.79 |
EV/EBITDA |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | 0.00 | (16.95) | (1.60) | (1.70) | (3.62) | (2.15) |
EV/FCF |
— | — | — | 0.00 | (16.95) | (1.02) | (1.37) | (3.22) | (2.04) |
Quick Ratio |
6.11 | 8.77 | 1.82 | 14.67 | 11.93 | 6.58 | 4.41 | 4.26 | 1.13 |
Current Ratio |
6.11 | 8.77 | 1.82 | 14.70 | 12.10 | 6.72 | 4.73 | 4.56 | 1.25 |
Net Debt/EBITDA |
0.57 | 1.24 | (0.38) | 7.66 | 5.06 | 2.74 | 1.07 | 1.14 | 0.08 |
Debt/Assets |
0.00% | 32.34% | 56.59% | 9.70% | 6.49% | 7.64% | 9.55% | 13.59% | 34.86% |
Debt/Equity |
1.16 | 0.56 | 3.64 | 0.11 | 0.07 | 0.09 | 0.12 | 0.19 | 0.84 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 | 0.03 | 0.07 |
Operating CF/Net income |
0.80 | 0.90 | 0.71 | 0.57 | 0.92 | 0.92 | 1.04 | 0.83 | 0.77 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (17.23) | (7.11) | (8.46) | (4.64) | (2.23) | (0.84) |
Interest Coverage |
(163.85) | (35.02) | 0.00 | (11.34) | (12.66) | (7.52) | (12.09) | (11.60) | (7.25) |
| (143.04%) | (119.47%) | (129.51%) | (24.61%) | (22.78%) | (21.74%) | (40.17%) | (56.07%) | (114.43%) | |
| (73.30%) | (101.00%) | (50.34%) | (18.98%) | (19.66%) | (18.48%) | (32.45%) | (41.92%) | (66.74%) | |
ROIC |
0.00% | 0.00% | 0.00% | (43.96%) | (67.76%) | (55.45%) | (54.08%) | (74.65%) | (122.99%) |
Return on Tangible Assets |
(111.47%) | (57.16%) | (169.55%) | (13.85%) | (21.16%) | (35.56%) | (74.38%) | (72.85%) | (552.43%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 8,698.39 | 1,076.13 | 383.23 | 501.16 | 497.00 | 271.86 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 685.66% | 276.17% | 514.30% | 612.95% | 759.23% | 427.39% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 10,904.06% | 1,304.35% | 611.38% | 498.78% | 629.53% | 481.65% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.38 | 0.14 | 0.15 | 0.27 | 0.38 | 0.32 | 0.42 |
Share Based Compensation of Revenue |
— | — | — | 3,695.05% | 149.06% | 87.48% | 60.05% | 87.77% | 48.76% |
Graham Net Nets |
— | — | — | 0.16 | 0.13 | 0.57 | 0.35 | 0.22 | (0.05) |
Graham Number |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | (7.19%) | (7.19%) | (23.82%) | (35.52%) | (24.38%) | (58.26%) |
Free Cash Flow Yield |
— | — | — | 0.00% | (5.07%) | (34.79%) | (45.60%) | (22.84%) | (46.95%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.13 | 0.17 | 0.15 | 0.30 |
Operating CF per Share |
(0.47) | (0.44) | (0.31) | (0.44) | (1.26) | (1.17) | (1.73) | (1.63) | (2.05) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.67) | (0.59) | (0.67) | (0.42) | (0.20) | (0.11) |
Free Cash Flow per Share |
(0.47) | (0.44) | (0.31) | (1.12) | (1.85) | (1.84) | (2.16) | (1.83) | (2.16) |
Cash per Share |
0.57 | 0.90 | 0.31 | 5.83 | 6.74 | 3.87 | 2.23 | 2.83 | 1.43 |
Shareholders Equity per Share |
0.25 | 0.56 | 0.12 | 6.13 | 7.39 | 4.91 | 3.79 | 3.74 | 1.46 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.25 | 0.56 | 0.12 | 6.13 | 7.39 | 4.91 | 3.79 | 3.74 | 1.46 |
Free Cash Flow |
(9.98) | (9.36) | (6.70) | (20.21) | (43.96) | (47.52) | (60.33) | (59.83) | (82.30) |
Working Capital |
10.77 | 17.86 | 4.04 | 100.19 | 152.01 | 89.92 | 58.34 | 82.84 | 13.87 |
Capital Expenditures |
(0.11) | (0.09) | (6.50) | (12.20) | (13.98) | (17.23) | (11.86) | (6.56) | (4.26) |
Net Current Asset Value |
4.90 | 11.51 | (5.46) | 88.21 | 139.43 | 78.51 | 45.69 | 57.28 | (9.20) |
EV/EBIT |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | — | — | 154.82 | 13.87 | 5.30 | 2.52 | 1.34 | 0.38 |
Price to Operating Income |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.24 | 0.28 | 0.31 | 0.87 | 0.82 | 0.79 | 0.56 | 0.57 | 1.11 |
Cash ROIC |
(41.65%) | (24.61%) | (35.47%) | (8.82%) | (12.58%) | (19.93%) | (33.25%) | (25.09%) | (52.55%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.04 | 0.42 | 1.02 | 0.95 | 0.75 | 1.50 |
Accounts Payable Turnover |
0.13 | 0.13 | 0.39 | 0.02 | 0.12 | 0.24 | 0.30 | 0.20 | 0.32 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.15 | 1.52 | 1.81 | 0.79 | 0.39 | 0.81 |
Average Days of Payables |
2,525.63 | 3,112.11 | 1,167.49 | 14,464.85 | 4,812.20 | 1,582.25 | 1,356.63 | 2,235.42 | 1,356.34 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 668.28 | 416.82 | 279.96 | 730.65 | 1,109.13 | 460.45 |
Average Receivables |
0.77 | 0.77 | 1.60 | 2.12 | 2.42 | 3.19 | 4.94 | 6.56 | 7.55 |
Average Payables |
0.83 | 0.83 | 1.24 | 1.46 | 3.04 | 4.99 | 5.96 | 8.47 | 12.91 |
Average Inventory |
— | — | — | 0.23 | 0.24 | 0.67 | 2.26 | 4.35 | 5.19 |
Average Assets |
17.05 | 10.33 | 18.87 | 73.69 | 166.21 | 178.00 | 144.14 | 152.89 | 152.72 |
Average Common Equity |
8.74 | 8.74 | 7.33 | 56.84 | 143.43 | 151.30 | 116.43 | 114.32 | 89.07 |
Columns are period end dates